Proteome Profiling of Neuroblastoma-derived Exosomes Reveal the Expression of Proteins Potentially Involved in Tumor Progression
Overview
Authors
Affiliations
Neuroblastoma (NB) is the most common extracranial solid tumor in childhood, with grim prognosis in a half of patients. Exosomes are nanometer-sized membrane vesicles derived from the multivesicular bodies (MVBs) of the endocytic pathway and released by normal and neoplastic cells. Tumor-derived exosomes have been shown in different model systems to carry molecules that promote cancer growth and dissemination. In this respect, we have here performed the first characterization and proteomic analysis of exosomes isolated from human NB cell lines by filtration and ultracentrifugation. Electron microscopy demonstrated that NB-derived exosomes exhibited the characteristic cup-shaped morphology. Dynamic light scattering studies showed a bell-shaped curve and a polydispersity factor consistent with those of exosomes. Zeta potential values suggested a good nanoparticle stability. We performed proteomic analysis of NB-derived exosomes by two dimension liquid chromatography separation and mass spectrometry analyses using the multidimensional protein identification technology strategy. We found that the large majority of the proteins identified in NB derived exosomes are present in Exocarta database including tetraspanins, fibronectin, heat shock proteins, MVB proteins, cytoskeleton-related proteins, prominin-1 (CD133), basigin (CD147) and B7-H3 (CD276). Expression of the CD9, CD63 and CD81 tetraspanins, fibronectin, CD133, CD147 and CD276 was validated by flow cytometry. Noteworthy, flow cytometric analysis showed that NB-derived exosomes expressed the GD2 disialoganglioside, the most specific marker of NB. In conclusion, this study shows that NB-derived exosomes express a discrete set of molecules involved in defense response, cell differentiation, cell proliferation and regulation of other important biological process. Thus, NB-derived exosomes may play an important role in the modulation of tumor microenvironment and represent potential tumor biomarkers.
Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives.
Rados M, Landegger A, Schmutzler L, Rabidou K, Taschner-Mandl S, Fetahu I Cancer Metastasis Rev. 2024; 43(4):1401-1417.
PMID: 39294470 PMC: 11554946. DOI: 10.1007/s10555-024-10212-8.
Cheng J, Ji D, Ma J, Zhang Q, Zhang W, Yang L Front Oncol. 2024; 14:1367159.
PMID: 39228987 PMC: 11368728. DOI: 10.3389/fonc.2024.1367159.
Comparative analysis of the exosomal contents of DF-1 cells infected by ALV-J.
Yang J, Zhuang P, Cheng Z, Wang G Vet Med (Praha). 2024; 67(2):87-98.
PMID: 39171213 PMC: 11334967. DOI: 10.17221/141/2020-VETMED.
The emerging role of the exosomal proteins in neuroblastoma.
Bhavsar S, Morini M Front Oncol. 2024; 14:1414063.
PMID: 38962276 PMC: 11219817. DOI: 10.3389/fonc.2024.1414063.
Extracellular vesicles in neuroblastoma: role in progression, resistance to therapy and diagnostics.
Dhamdhere M, Spiegelman V Front Immunol. 2024; 15:1385875.
PMID: 38660306 PMC: 11041043. DOI: 10.3389/fimmu.2024.1385875.